First Eagle Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$870M Buy
10,044,695
+269,461
+3% +$25.8M 1.48% 27
2025
Q4
$939M Buy
9,775,234
+40,196
+0.4% +$3.9M 1.65% 23
2025
Q3
$927M Buy
9,735,038
+2,820
+0% +$259K 1.69% 20
2025
Q2
$848M Sell
9,732,218
-83,431
-0.8% -$7.08M 1.67% 20
2025
Q1
$882M Buy
9,815,649
+23,449
+0.2% +$2.1M 1.84% 20
2024
Q4
$782M Buy
9,792,200
+28,910
+0.3% +$2.5M 1.75% 21
2024
Q3
$879M Buy
9,763,290
+386,733
+4% +$32.5M 1.81% 21
2024
Q2
$738M Sell
9,376,557
-38,599
-0.4% -$3.16M 1.65% 23
2024
Q1
$821M Buy
9,415,156
+5,476
+0.1% +$467K 1.86% 20
2023
Q4
$775M Buy
9,409,680
+3,320,800
+55% +$253M 1.85% 21
2023
Q3
$477M Buy
6,088,880
+592,849
+11% +$49.6M 1.23% 30
2023
Q2
$484M Buy
5,496,031
+10,692
+0.2% +$920K 1.24% 32
2023
Q1
$442M Buy
5,485,339
+3,324,768
+154% +$271M 1.17% 33
2022
Q4
$168M Buy
2,160,571
+1,971,275
+1,041% +$160M 0.46% 58
2022
Q3
$15.3M Sell
189,296
-573
-0.3% -$51.5K 0.05% 79
2022
Q2
$17M Hold
189,869
0.05% 75
2022
Q1
$21.1M Hold
189,869
0.05% 74
2021
Q4
$19.6M Sell
189,869
-618
-0.3% -$71.6K 0.05% 79
2021
Q3
$23.9M Sell
190,487
-1,640
-0.9% -$212K 0.06% 73
2021
Q2
$23.8M Sell
192,127
-32,597
-15% -$4.09M 0.06% 75
2021
Q1
$26.5M Sell
224,724
-2,275
-1% -$267K 0.07% 75
2020
Q4
$26.6M Sell
226,999
-2,293
-1% -$252K 0.07% 75
2020
Q3
$23.8M Buy
+229,292
New +$23M 0.07% 76
2018
Q1
Sell
-1,434
Closed -$116K 242
2017
Q4
$116K Hold
1,434
﹤0.01% 275
2017
Q3
$112K Hold
1,434
﹤0.01% 295
2017
Q2
$127K Hold
1,434
﹤0.01% 270
2017
Q1
$116K Hold
1,434
﹤0.01% 263
2016
Q4
$102K Sell
1,434
-395,604
-100% -$31.1M ﹤0.01% 266
2016
Q3
$34.3M Sell
397,038
-708,976
-64% -$61.8M 0.09% 131
2016
Q2
$96M Sell
1,106,014
-727,779
-40% -$58.9M 0.24% 98
2016
Q1
$138M Sell
1,833,793
-106,243
-5% -$8M 0.35% 87
2015
Q4
$149M Buy
1,940,036
+1,922,301
+10,839% +$145M 0.37% 90
2015
Q3
$1.19M Buy
17,735
+5,000
+39% +$368K ﹤0.01% 213
2015
Q2
$944K Sell
12,735
-924,437
-99% -$70.6M ﹤0.01% 222
2015
Q1
$73.1M Sell
937,172
-299,142
-24% -$22.7M 0.17% 106
2014
Q4
$89.3M Sell
1,236,314
-554,170
-31% -$38.5M 0.22% 95
2014
Q3
$111M Sell
1,790,484
-307,859
-15% -$19.6M 0.28% 88
2014
Q2
$134M Buy
+2,098,343
New +$127M 0.32% 76
2014
Q1
Sell
-8,000
Closed -$459K 400
2013
Q4
$459K Hold
8,000
﹤0.01% 251
2013
Q3
$426K Hold
8,000
﹤0.01% 244
2013
Q2
$412K Buy
+8,000
New +$395K ﹤0.01% 271

Other funds holding MDT

First Eagle Investment Management's MDT Position: Q1 2026 in Review

First Eagle Investment Management increased its Medtronic (MDT) stake by 2.8% in Q1 2026, buying an estimated $25.8M and bringing the position to 10,044,695 shares worth $870M. The position accounts for 1.48% of the portfolio, ranked #27.

First Eagle Investment Management first reported a position in MDT in Q2 2013 and has held it in 41 quarters since. The position peaked at $939M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • First Eagle Investment Management held 10,044,695 shares of Medtronic worth $870M as of Q1 2026.
  • First Eagle Investment Management bought 269,461 Medtronic shares in Q1 2026, an estimated $25.8M.
  • Medtronic made up 1.48% of First Eagle Investment Management's portfolio in Q1 2026, its #27 holding.
  • First Eagle Investment Management first reported a position in Medtronic in Q2 2013 and has held it in 41 quarters since.
  • First Eagle Investment Management's Medtronic position peaked at $939M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on First Eagle Investment Management's 13F filing for Q1 2026, filed 12 May 2026.